Compare SEVN & INFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SEVN | INFU |
|---|---|---|
| Founded | 1986 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 187.6M | 208.8M |
| IPO Year | 2008 | 2005 |
| Metric | SEVN | INFU |
|---|---|---|
| Price | $8.49 | $9.28 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | $10.50 | ★ $15.00 |
| AVG Volume (30 Days) | 69.4K | ★ 256.6K |
| Earning Date | 04-28-2026 | 05-07-2026 |
| Dividend Yield | ★ 13.90% | N/A |
| EPS Growth | N/A | ★ 181.82 |
| EPS | ★ 0.19 | 0.05 |
| Revenue | $29,383,000.00 | ★ $143,436,000.00 |
| Revenue This Year | $27.75 | $3.20 |
| Revenue Next Year | $4.06 | $7.31 |
| P/E Ratio | ★ $44.63 | $182.40 |
| Revenue Growth | N/A | ★ 6.36 |
| 52 Week Low | $7.90 | $5.43 |
| 52 Week High | $12.85 | $11.04 |
| Indicator | SEVN | INFU |
|---|---|---|
| Relative Strength Index (RSI) | 53.05 | 49.32 |
| Support Level | $8.33 | $8.57 |
| Resistance Level | $8.95 | $9.97 |
| Average True Range (ATR) | 0.18 | 0.51 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 48.80 | 38.85 |
Seven Hills Realty Trust is a real estate investment trust. The company is engaged in originating and investing in floating-rate first mortgage loans secured by middle-market and transitional commercial real estate. Its primary objective is to balance capital preservation with the generation of risk-adjusted returns. The company operates in one business segment: originating and investing in floating-rate first mortgage loans secured by CRE properties.
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. The company's services are provided under two-reportable segments: Patient Services and Device Solutions. Maximum revenue is generated from its Patient Services segment, which provides Durable Medical Equipment (DME) and treatment consumables, handles order and delivery logistics, provides 24/7 nursing support relating to the provided equipment, assumes responsibility for third-party payer Durable Medical Equipment billing, and handles biomedical services for the Durable Medical Equipment. The Device Solutions segment includes equipment rental and sales, consumable sales, and biomedical support services.